Enact Holdings, Inc. (ACT) stock analysis
Close on Nov 11, 2026Market cap $6.35BP/E 9.6Yield 1.77%
StockData Score
Prices as of Nov 11, 2026How the score works
Weak6 of 30 checks passed
Enact passes 6 of the 30 checks behind our score; 17 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 4/6
- Growth
- 0/6
- Past performance
- 1/6
- Financial health
- 0/6
- Dividend
- 1/6
What stands out
Margin of safety over 20%
The price is 53.7% below fair value, more than the 20% cushion we look for.
Trading below fair value
The share price of $46.16 is below our fair value estimate of $99.78.
Earnings grew over 5 years
Net income grew 12.7% a year on average over the last five fiscal years.
P/E below the industry
Enact's P/E of 9.6 is below the Insurance Agents, Brokers, and Service median of 30.1.
What to watch
Revenue growing under 10% a year
Revenue grew 4.1% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew 1.6% a year over the last three fiscal years.
P/E above its 5-year median
Enact's P/E of 9.6 is above its own 5-year median of 7.5.
P/S above the industry
Enact's price-to-sales of 5.06 is above the Insurance Agents, Brokers, and Service median of 3.43.
Valuation4/6
P/E above its 5-year median
Enact's P/E of 9.6 is above its own 5-year median of 7.5.
P/E below the industry
Enact's P/E of 9.6 is below the Insurance Agents, Brokers, and Service median of 30.1.
P/S above the industry
Enact's price-to-sales of 5.06 is above the Insurance Agents, Brokers, and Service median of 3.43.
P/B below the industry
Enact's price-to-book of 1.22 is below the Insurance Agents, Brokers, and Service median of 4.81.
Trading below fair value
The share price of $46.16 is below our fair value estimate of $99.78.
Margin of safety over 20%
The price is 53.7% below fair value, more than the 20% cushion we look for.
Growth0/6
Revenue growing under 10% a year
Revenue grew 4.1% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew 1.6% a year over the last three fiscal years.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing slower than the industry
Revenue grew 2.5% over the last twelve months; the Insurance Agents, Brokers, and Service median is 13.8%.
Guidance issued
The latest outlook (Full-Year Capital Return, Aug 5, 2026) was issued for the first time, so it neither adds nor takes away points.
Gross margin trend
Banks and insurers do not report gross profit.
Past performance1/6
Return on equity
Needs positive equity and five years of results.
Return on assets
Needs net income and total assets.
Return on equity against the industry
Needs positive equity.
Earnings grew over 5 years
Net income grew 12.7% a year on average over the last five fiscal years.
Net margin against its history
Needs five years of revenue and net income.
Net margin against the industry
Needs revenue and net income.
Financial health0/6
Debt level
Needs debt and equity figures.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt coverage
Needs operating cash flow.
Interest coverage
Interest expense is not reported separately.
Short-term liquidity
Insurers do not split assets into current and non-current.
Bankruptcy risk (Altman Z)
The Altman model does not apply to insurers.
Dividend1/6
Pays a dividend
Enact paid dividends worth 1.9% of the share price over the last twelve months.
Yield below Treasuries
The 1.9% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; Enact yields 1.9%.
Dividend stability
Fewer than five years of dividend history.
Earnings cover
Needs dividends paid and net income.
Cash-flow cover
Needs dividends paid and free cash flow.
Fair value
How we estimate itOur estimate per share
$99.78
The share price is 54% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 18.7× | 7.5× | 30.1× | $89.86 | 50% |
| P/B | 2.9× | 1.0× | 4.8× | $109.70 | 50% |
| Fair value | $99.78 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 7.5
- Insurance Agents, Brokers, and Service median 30.1
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Medium risk
- Average value traded per day
- $19.93M
- Value traded per 1% price move
- $16.52M
Downside
Low risk
- Typical loss in a bad month
- 8.3%
- Volatility (annualized)
- 23%
- Sharpe ratio, 1 year
- 0.83
- Beta to the S&P 500 (5Y)
- 0.51
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2018 to 2025
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +2.8% | +4.1% | +2.2% | – | |
| Net income | -2.0% | – | +12.7% | – | |
| EPS, diluted | +3.4% | +1.6% | +14.8% | – | |
| Dividend per share | +14.0% | -19.1% | – | – |
Returns and balance sheet
8 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2018 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | 9.6% | 13.0% | |
| Return on assets | – | – | 10.1% | |
| Diluted shares | – | 163M | 149M |
Cash use needs five years of cash flow figures
Enact does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 54.6% | 0.18× | 1.30× | 13.0% |
| FY2024 | 57.3% | 0.19× | 1.32× | 14.3% |
| FY2023 | 57.7% | 0.19× | 1.36× | 15.2% |
| FY2021 | 48.9% | 0.19× | 1.44× | 13.7% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$674.24M
- Cash generatingOperating cash flow above zero$724.52M
- Return on assets improvedROA up on the prior year11.1% → 10.3%
- Earnings backed by cashOperating cash flow above net income$724.52M vs $674.24M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise158M → 149M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.19 → 0.19
See a number that looks wrong?